Details for 2020828324

Up to date per 01.04.2026

Actions

Title / Product Name

EINMAL TÄGLICHES KREBSBEHANDLUNGSREGIME MIT EINEM PRMT5-INHIBITOR

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2020828324

EP Publication Number

4076465

E-Number

1631165

Language

PCT Number

IB20061957

Publication Date

26.10.2022 A

15.11.2023 B1

Registration Date

15.11.2023

AT Publication Date

15.12.2023

Application Date

15.12.2020

Registration Number

Priorities

18.12.2019

201962949688 P

17.08.2020

202063066755 P

02.11.2020

202063108745 P

IPC

A61K 31/519 20060101AFI20230526BHEP

Maximum Duration of Protection

15.12.2040

Owner

Pfizer Inc.66 Hudson Boulevard East New York, NY 10001-2192US

Representative

No representatives present

Inventor

LI, Mengc/o Pfizer Inc. 10777 Science Center Drive San Diego, California 92121US

LIAO, Kai-Hsinc/o Pfizer Inc. 10777 Science Center Drive San Diego, California 92121US

YAMAZAKI, Shinji3884 Quarter Mile Drive San Diego, California 92130US